Work

Abstract 4339897: Lipid lowering effects of inclisiran in statin- or PCSK9i monoclonal antibody-intolerant patients

Year: 2025

Type: conference-abstract

Source: Circulation

DOI: 10.1161/circ.152.suppl_3.4339897

Authors: Ashish Sarraju, Astefanos Al-Dalakta, Kathy Gambino, Erik Van Iterson, Ryan Tang, Bianca Honnekeri, Stanley Hazen, Luke Laffin, Dennis Bruemmer, Julie Huang, Abhayjit Singh, Vikas Sunder, Leslie Cho

Institution: Cleveland Clinic

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415790031

Cites:

Cited by:

Related to: